BITHYRX
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Jan 2023)
What this means for you
This application is over — abandoned 02 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88702667
- Mark type
- Stylized text
- Filed
- 22 Nov 2019
- Published for opposition
- 07 Apr 2020
- Abandoned
- 02 Jan 2023
- Attorney of record
- Daniel J. Chalker
Goods and services
- Class 005 — Pharmaceuticals: Extended release thyroid medicine
Owner
- Spectrix Therapeutics, LLC, Southlake, TX, US
- Spectrix Therapeutics, LLC, Southlake, TX, US
Prosecution history
- 03 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Apr 2022 — SOU EXTENSION 4 GRANTED
- 26 Apr 2022 — SOU EXTENSION 4 FILED
- 26 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2021 — SOU EXTENSION 3 GRANTED
- 02 Nov 2021 — SOU EXTENSION 3 FILED
- 02 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Jun 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jun 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Jun 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2021 — SOU EXTENSION 2 GRANTED